Senior Director @ PSI CRO | Global Late Phase Studies Oncology, Radiopharm, Hemato-Onco, Supportive Care, IPF, Haemophilia, BD, MS, anti-infectives, anti-fungals. Long-standing PCMG Assembly Steering Committee member.
Let ‘s discuss your next theranostic or radiopharm study
The PSI team is headed to Toronto, Canada next month for SNMMI! Join us June 8-11 at booth #624 to meet our team of radiopharm experts. Schedule some time to meet with us now: https://bit.ly/3WkFoq9
Just a reminder that David Heal of DevelRx Ltd will be attending the Safety Pharmacology Society Annual Meeting to be held at the Town and Country Resort, San Diego, California, USA, 22nd to 25th September 2024. Details of our posters are: David Heal, Jane Gosden, Sharon Smith. Discriminating Evidence – Use and Misuse of the Drug Discrimination Test in Abuse Potential Assessments of Novel CNS Drugs. Poster Number 026-C. David Heal, Jane Gosden, Sharon Smith. Intravenous Self-administration – Valid Experimental Designs to Evaluate the Abuse Potential of Psychedelics, Entactogens and Drugs with Novel Mechanisms. Poster Number 027-C. Poster presentation times are: 23rd September 2024. Poster Session 1. 3.00-3.45 pm. 24th September 2024. Poster Session 2. 9.15-10.00 am. Golden State Ballroom. David will also be describing the refinements to IVSA methodology required to test the new generation of CNS drugs (Poster 027) as an oral communication (Oral Communications 2. CNS/Respiratory. 23rd September 2.00-2.15 pm. Town & Country Ballroom D). If you would like to see David at the SPS meeting please get in touch or visit our posters. If your company is based in San Diego and you would like to see David while he is in the area please contact us via inform@develrx.com #2024SPS #safetypharmacology #abusepotential #psychedelics #drugdevelopment https://lnkd.in/eE39PrPY
CEO at Takis, Evvivax & NeoMatrix | President at Vitares | Board Member at Assobiotec, Rome Technopole, Genomica & Terapia, CN3, MNESYS & Campania Oncoterapie
An important milestone reached on our pathway towards Epidemic/Pandemic Preparedness. Looking forward to next steps to complete the entire Research Chain, from ideas to therapies in just few weeks. Yes, we can at Takis. Takis #geneticvaccines #epidemicpreparedness
Have you not been able to attend the inauguration of our new BSL-3? Or you simply want to live it all over again? Enjoy this throwback video! The event brought together key figures from the biotech and political sectors, all emphasizing one essential point: this lab is a crucial step forward for scientific research and epidemic preparedness in Italy. In this video you can listen to small extracts from the speeches and enjoy the event as if you were there! The BLS-3 module, which is already operational, represents a fundamental step towards creating innovative "Made in Italy" therapies. We thank all the participants and speakers, who contributed to the success of the BSL-3 inauguration: Giuliano Peretti, ANASPI General Manager; Giuseppe Biazzo, President of Unindustria Roma - Frosinone - Latina - Rieti - Viterbo; Giancarlo De Matthaeis, President of Labozeta SpA; Prof. Rino Rappuoli, Siena Biotecnopolo Scientific Director; Lorenzo Tagliavanti, President of the Camera di Commercio Roma; On. Edy Palazzi, Councilor of the Regione Lazio; On. Luciano Ciocchetti, Deputy of the Camera dei deputati; and Sen. Marco Silvestroni, Senator of the Senato della Repubblica. We thank of course our COO Emanuele Marra, our CTO Giuseppe Roscilli and CEO Luigi Aurisicchio, and all Takis staff for all the dedication in making this incredible step forward possible. At Takis, we don’t aim to be a big company at all costs; we aim to do great research, and this module will let us do exactly that! Unindustria Roma - Frosinone - Latina - Rieti - Viterbo | Assobiotec
Gauss, from the suppliers' pillar of the CRMDC, invites you to participate in the first edition of the Costa Rica MD Summit. 🇨🇷🔬 Come and learn more about the industry. #medicaldevices #medicaldevicescostarica #medicalcomponents #gauss #mdsummit
The 42nd VICENZA COURSE on AKI, CRRT & ECOS is approaching! (Vicenza, June 11-13) Don’t miss the Meet the Expert session “Polymyxin B Hemoadsorption in Endotoxic Septic Shock: What We Learned till Now from Asia, Europe and US Clinical Experiences”. Save the Date: Tuesday, June 11 | 18.00 – 18.30 #Endotoxemia #EndotoxicShock #SAAKI #PolymyxinBAdsorption #PatientFirst
Are you attending the 2024 Safety Pharmacology Society Annual Meeting? Are you ready to share your science at the DSI Data Blast?💥 THE BLAST IS BACK and there’s 1️⃣ week left to submit your abstract and ✅ the box for Blast participation. SPS abstract submission ➡️ https://ow.ly/RA5m50R3LVy #2024SPS #safetypharmacology #drugdiscovery
JAFRON HA SERIES What it is - What it is not. This series of articles are our experiences with the Jafron HA series, especially in clinics in Turkey and in our direct relationships with Jafron. - Examining all aspects of the products in this article series - Known and unknown details of product differences - Our clinical development processes and market reflections -CE; MDR and prospectus details - Our field sales strategies and competitor analysis - Third world countries and European perspective: Where is Türkiye - Overview of clinical studies. Why do we stay away from prospective studies? - Many topics such as our 10-year adventure from amateur to professional will be discussed in detail. The purpose of this series of articles is to share our experiences by covering all the processes of an evolving treatment. In this sense, we think that "What it is - What it is not" is the most appropriate title for us. We start on Friday, March 22nd. #jafron #cytokine #hemoperfusion #hemoadsorption #sepsis #cytosorb #oxiris #cpfa #seraph100 #efferon
✨ EADV Congress 2024 ✨ For all roles in pharma, achieving congress objectives requires a different approach to the ‘day job’. David Barwick and Mark Wilson recently attended the EADV congress to support one of our partners to do just that. Check out the team in action! Get in touch with us to learn more about the holistic congress offering that was causing a stir in Amsterdam! #EADVCongress #EADVCongress2024 #CongressObjectives #EventObjectives
Neurochirurgo presso UOSD Terapia Antalgica Interventistica e Chirurgica - Az. Osp. San Giovanni Addolorata
Starting to organize, with colleagues and friends, workshops and scientific sessions of this outstanding International Congress : the new edition of Roma Pain Days (April 2025). Don’t miss it #pain #paintherapy #neurosurgery #terapiadolore #dolore #neuromodulation #spine #endoscopy #spinalendoscopy #diabetes #spinalcordstimulation
Abdallah Allam Tolga Ergönenç Dr Marco Narvaez Daniele Battelli Avetis Avetisyan Rinaldi Riccardo stefano meloncelli Marco Mercieri, MD, PhD Joseph Pergolizzi, MD Sonia Khalbous Panagiotis Zis Magdi hanna Magdi R. Iskander Narinder Rawal Eleni Moka, MD, PhD, MSc, EDRA Roberto Gazzeri Dra. Rocio Guillen Diego Fornasari Anthony Dickenson MENARINI Group Menarini Asia-Pacific Berlin-Chemie Menarini Viatris Abbott Medtronic Pain Interventions #RPD-5 (April 10-12, 2025), the new edition of the Roma Pain Days congress will impress you with scientific sessions and workshops. Once again, you will have the possibility to be present in a magnificent location or take the advantage of the online event. Do not miss it!
Not long to go until ADLM! Come and visit Biofortuna at booth 3157, or book a meeting in advance (https://bit.ly/3SdjWjU), to: ✅ Explore how our customised genomics services can propel your research forward. ✅ Discover how we facilitate molecular diagnostics development through adaptable assay design. ✅ Gain insights into how Lyophilised beads can streamline your assay development process and enhance product stability. ✅ Share your specific requirements for manufacturing IVD kits. Our team is eager to share their experience and explore how we can support your scientific and clinical goals. #ADLM #AssayDevelopment #Chicago #MolecularDiagnostics #Lyophilization
Dear Jeevan, it was fantastic to have you on the panel. We had a real #TeamEurope on stage with a lot of constructive ideas and solutions. Thanks to All for being great sparring partners, candid and open. #diaeurope2024 platform proved its value again - but let's continue the conversation on how to make Europe truly attractive and competitive: cut red tape, simplify the legislative maze, create certainty for investors, resource regulators & other enablers of innovation, get everybody out of their silos, facilitate partnerships and intersectorial mobility, and think creatively about funding sources from philanthropy to VC and everything in between. What else? Pedro Franco, Ferenc Marofka, Virginie HIVERT, Steffen Thirstrup, Annette Bakker, Emma Du Four BSc (Hons) MBA FTOPRA
How do we make the European life science sector of tomorrow attractive? That’s the topic I’ll dive into today at #DIAEurope, where I'll join a panel of key stakeholders and policymakers to examine Europe’s place on the Biopharmaceutical Innovation Map. The #EUPharmaLegislation review is a unique opportunity to evolve Europe's life-sciences ecosystem. As research and development of innovative treatments for patients begins to move to the US and Asia, Europe must act. Now is the time to be ambitious as we shape the European life sciences ecosystem. Very pleased to sit on the panel chaired by the amazing Magda Chlebus, with Pedro Franco speaking and Ferenc Marofka, Virginie HIVERT, Steffen Thirstrup & Annette Bakker joining me as panellist. https://lnkd.in/esEuerVb
